Lumibird (LBIRD) Q2 2024 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 TU earnings summary
23 Jul, 2026Executive summary
Consolidated revenues for H1 2024 reached €98.0m, up 1% year-over-year, impacted by a strong base effect from H1 2023's 16% growth.
Business was affected by delayed orders in Asia, but development opportunities remain robust.
The group maintains its 3-year targets for revenue growth (CAGR >8%) and profitability improvement (+500 bps EBITDA margin).
Financial highlights
H1 2024 revenues: €98.0m (+1% reported, +2% constant FX, -2% like-for-like).
Q1 2024 revenues: €43.9m (+7% YoY); Q2 2024: €54.1m (-4% YoY).
EBITDA margin expected to improve in FY 2024 from 17% in 2023.
Outlook and guidance
Revenue growth target (CAGR >8%) and EBITDA margin improvement (+500 bps) reaffirmed through 2026.
Profitability expected to improve in 2024, though H1 margin impacted by sales level.
Solid order book, with new multi-year contracts expected, especially in defense.
Latest events from Lumibird
- Photonics revenue jumped 15.3% while Medical stabilized, driving 7.4% overall growth.LBIRD
Q2 2026 TU27 Jul 2026 - H1 2024 saw stable revenue, margin pressure from Convergent, and a positive outlook.LBIRD
H1 202423 Jul 2026 - Revenue up 1.7% to €207.1M, Medical strong, Photonic down, net income falls 20.1%.LBIRD
H2 202423 Jul 2026 - Revenue up 9%, EBITDA up 85%, net income €4.9M, with strong divisional growth.LBIRD
H1 202523 Jul 2026 - EBITDA up 38%, net income up 146%, and revenue up 8.9% on strong divisional growth.LBIRD
H2 202523 Jul 2026 - Sales rose 1.7% to €207.1m, driven by Medical growth and strong cash position.LBIRD
Q4 2024 TU23 Jul 2026 - Medical growth and Continuum acquisition drive momentum; 9-month revenue up 2%.LBIRD
Q3 2024 TU23 Jul 2026 - Q1 2025 revenue rose 12.4% year-over-year, driven by Defence/Space and Medical growth.LBIRD
Q1 2025 TU23 Jul 2026 - H1 2025 revenue up 9% to €106.8M, with strong growth in both Photonics and Medical divisions.LBIRD
Q2 2025 TU23 Jul 2026